24 January 2014
Change in composition of inflammatory infiltrate in the course of hepatitis C reinfection and concomitant acute rejection after orthotopic liver transplantation
Bogna Ziarkiewicz-WróblewskaABDEFG, Tadeusz WróblewskiBDF, Michał CiszekBD, Piotr KalinowskiBE, Jacek MalejczykCDEFDOI: 10.12659/AOT.884034
Ann Transplant 2014; 19:41-50
Abstract
BACKGROUND: Hepatitis C virus (HCV) reinfection occurs in almost all patients after orthotopic liver transplantation (OLT) for HCV related liver cirrhosis and presents serious therapeutic challenge for a transplant team. The reinfection is concomitant with other posttransplant complications that influence presentation of the disease. Microscopic histological examination of a liver biopsy specimen remains the standard diagnostic procedure. The aim of the study was to analyze the composition of inflammatory infiltrate in HCV reinfection and determine whether its features may help in the differentiation between HCV reinfection and acute rejection (AR).
MATERIAL AND METHODS: Seventy seven post-OLT liver biopsy specimens from patients after OLT for HCV related cirrhosis were examined. Characteristics of inflammatory infiltrate and changes in its composition related to a time interval between OLT and biopsy and concomitant AR were analyzed.
RESULTS: Significant differences in the composition of inflammatory infiltrate between the analyzed time intervals between OLT and biopsy were found. In the group of patients with HCV reinfection and concomitant AR the infiltrate was significantly more extensive than in the patients with HCV reinfection alone with predominantly CD8+ and CD5+ lymphocytes responsible for this finding.
CONCLUSIONS: Significant changes in inflammatory infiltrate contents were found depending on the time period between OLT and graft biopsies.
Keywords: liver transplantation, HCV reinfection, Immunophenotyping
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






